Fundação de Medicina Tropical Dr Heitor Vieira Dourado (FMT-HVD)
Welcome,         Profile    Billing    Logout  
 4 Trials 
2 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lacerda, Marcus VG
NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Completed
3
750
RoW
Active, Placebo
Butantan Institute, Valneva Austria GmbH
Chikungunya
02/23
02/24
DOVETAIL, NCT06497465: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Not yet recruiting
3
150
RoW
Dolutegravir 50mg Tab, TIVICAY 50 mg, TIVICAY PD, Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO], Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)
Johns Hopkins University, ViiV Healthcare
Tuberculosis, HIV
01/28
01/29
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lacerda, Marcus VG
NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Completed
3
750
RoW
Active, Placebo
Butantan Institute, Valneva Austria GmbH
Chikungunya
02/23
02/24
DOVETAIL, NCT06497465: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Not yet recruiting
3
150
RoW
Dolutegravir 50mg Tab, TIVICAY 50 mg, TIVICAY PD, Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO], Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)
Johns Hopkins University, ViiV Healthcare
Tuberculosis, HIV
01/28
01/29

Download Options